https://ogma.newcastle.edu.au/vital/access/ /manager/Index en-au 5 https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:52173 Wed 04 Oct 2023 11:03:26 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54408 Tue 27 Feb 2024 13:50:09 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:36272 Thu 28 Oct 2021 12:36:00 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:9405 12 on the EPDS and/or positive on the “interval symptom” question were then administered the CIDI. A further 65 randomly selected women that screened negative were also administered the CIDI. Loss to postnatal follow-up was very significant, and returns rates were inconsistent across the three postnatal time points. Almost 25% of those who screened positive did not complete a CIDI. For screen-positive status, a total of 314 (24.4%) of those that returned questionnaires (N=1,289) screened positive at least once across the 6- to 8-month interval. Of these, 79 were lost to follow-up; thus, 235 (74.8%) completed a CIDI. In this group, 34.7% had been positive both on the EPDS and the “interval” question, 15.9% on the EPDS alone, and 49.4% on the “interval” question alone. For the CIDI diagnosis and estimated 6- to 8-month period CIDI prevalence, among those 235 women who screened positive and completed a CIDI, 67.2% met the criteria for a CIDI diagnosis, as did 16.9% of those who screened negative. The breakdown in CIDI diagnoses in the 235 women was 32.8% major depression (± anxiety disorder); 26.4% minor depression alone; and 8.1% with a primary anxiety disorder (approximately half with minor depression). Put another way, 20.4% of these women had an anxiety disorder (approximately two thirds with comorbid depression) and 37.7% of women with a major depressive episode (MDE) had a comorbid anxiety disorder. The estimated 6- to 8-month prevalence rate for a CIDI diagnosis of anxiety or depression (major or minor) was 29.2% (95% CI 26.7%–31.7%). The use of the “interval symptom” question alone was 1.7 times more likely to identify positive CIDI cases than the EPDS alone. Almost 40% of postnatal women with a diagnosis of MDE have a comorbid diagnosis of anxiety disorder. The estimated 6- to 8-month period prevalence for CIDI cases of anxiety and depression was 29.2%. Screening for anxiety and depression using the EPDS alone was associated with a lesser capacity to identify CIDI caseness than a simple “interval symptom” question (for the 2 months prior) which almost doubled the yield. This paper demonstrates that combining the EPDS with the “interval symptom” question improves detection of CIDI caseness.]]> Sat 24 Mar 2018 08:39:33 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:1024 Sat 24 Mar 2018 08:29:47 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:24306 positive life investments', Component 2 'poor emotional regulation' and Component 3 'poor health behaviours'. There was a significant negative correlation between 'positive life investments' and each of the Depression, Anxiety and Stress scales subscales and significant positive associations with 'poor emotional regulation' and Short Form Health Survey-12 mental health scores. Only the Short Form Health Survey-12 physical health subscale was weakly correlated with 'poor health behaviours', in females. Conclusion: Our findings support the construct and concurrent validity of the Fantastic Lifestyle Checklist measure. The three factors obtained for the Fantastic Lifestyle Checklist were coherent and seem useful for research and clinical practice.]]> Sat 24 Mar 2018 07:14:39 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:54828 Fri 15 Mar 2024 11:54:55 AEDT ]]> https://ogma.newcastle.edu.au/vital/access/ /manager/Repository/uon:40583 Fri 15 Jul 2022 10:46:19 AEST ]]>